- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05699200
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
June 15, 2026 updated by: Marysia Tweet, Mayo Clinic
Role of the Neurovascular System in Spontaneous Coronary Artery Dissection (SCAD)
The purpose of this research is to compare sympathetic function (flight or fight system) and arterial health including structure and mechanics of participants with history of spontaneous coronary artery dissection (SCAD) to age and sex matched control participants.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pamela Engrav
- Phone Number: 507-255-6938
- Email: Engrav.Pamela@mayo.edu
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- For SCAD patients: history of SCAD as confirmed by coronary angiography or cardiac computed tomography angiography
- For controls: no cardiac disease history
Exclusion Criteria:
- Pregnancy
- Known or suspected unstable cardiac condition within 4 weeks of the study
- Active treatment with anticoagulation or dual antiplatelet therapy
- Prisoner
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Spontaneous coronary artery dissection (SCAD) group
Subject with a history of SCAD will undergo a series of diagnostic studies to assess neurovascular function.
|
We will measure arterial stiffness using arterial tonometry.
We will collect limited ultrasound images of the heart.
We will perform ultrasound imaging of the carotid artery.
We will measure the elastic properties of the arteries using elastography.
We will measure the ankle-brachial index to assess peripheral artery blood flow.
We will measure sympathetic nerve activity at rest and in response to isometric handgrip, mental stress test, cold pressor test, Valsalva maneuvers.
|
|
Other: Healthy Control Group
Healthy subjects will undergo a series of diagnostic studies to assess neurovascular function.
|
We will measure arterial stiffness using arterial tonometry.
We will collect limited ultrasound images of the heart.
We will perform ultrasound imaging of the carotid artery.
We will measure the elastic properties of the arteries using elastography.
We will measure the ankle-brachial index to assess peripheral artery blood flow.
We will measure sympathetic nerve activity at rest and in response to isometric handgrip, mental stress test, cold pressor test, Valsalva maneuvers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial thickness
Time Frame: Baseline
|
Measured by carotid ultrasound intimal media thickness reporting in mm
|
Baseline
|
|
Arterial stiffness
Time Frame: Baseline
|
Measured by carotid ultrasound pulse wave velocity reporting in m/s
|
Baseline
|
|
Baroreflex sensitivity
Time Frame: Baseline
|
The slope between heart rate and blood pressure at rest and during the Valsalva Maneuver (ms/mmHg)
|
Baseline
|
|
Sympathetic response to stress
Time Frame: Baseline
|
Blood pressure or muscle sympathetic nerve activity response to sympathoexcitatory stressors (mm/Hg or bursts/min).
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Marysia Tweet, MD, MS, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Study Registration Dates
First Submitted
January 16, 2023
First Submitted That Met QC Criteria
January 16, 2023
First Posted (Actual)
January 26, 2023
Study Record Updates
Last Update Posted (Actual)
June 17, 2026
Last Update Submitted That Met QC Criteria
June 15, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Dissection, Blood Vessel
- Acute Aortic Syndrome
- Cardiovascular Diseases
- Heart Diseases
- Congenital Abnormalities
- Cardiovascular Abnormalities
- Heart Defects, Congenital
- Aortic Diseases
- Aneurysm
- Coronary Artery Dissection, Spontaneous
- Diagnostic Techniques and Procedures
- Diagnosis
- Diagnostic Imaging
- Diagnostic Techniques, Cardiovascular
- Heart Function Tests
- Cardiac Imaging Techniques
- Ultrasonography
- Echocardiography
- Ultrasonography, Carotid Arteries
- Elasticity Imaging Techniques
Other Study ID Numbers
- 21-005636
- 1K23HL155506 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.